APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Circular mRNA Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Circular mRNA Drugs Industry Growth and Trends Forecast to 2032

27 December 2025108 pages

Choose your research edition.

Industry ResearchCircular mRNA Drugs Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Circular mRNA Drugs Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Circular mRNA Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Circular mRNA Drugs Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Circular mRNA Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Circular mRNA Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Circular mRNA Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Circular mRNA Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Circular mRNA Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Circular mRNA Drugs include Chimera Therapeutics, Orbital Therapeutics, Orna Therapeutics, Sail Biomedicines, Torque Bio, Aikang Pharmaceuticals, Edigene, CirCode and Curemed Bio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Circular mRNA Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Circular mRNA Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Circular mRNA Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Circular mRNA Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Circular mRNA Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Circular mRNA Drugs Market by Company

Chimera Therapeutics

Orbital Therapeutics

Orna Therapeutics

Sail Biomedicines

Torque Bio

Aikang Pharmaceuticals

Edigene

CirCode

Curemed Bio

Therorna

Circular mRNA Drugs Segment by Type

Preventive Medicine

Medicine

Circular mRNA Drugs Segment by Application

Infectious Disease

Cancer

Others

Circular mRNA Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Circular mRNA Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Circular mRNA Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Circular mRNA Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Circular mRNA Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Circular mRNA Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Preventive Medicine Table 2. Major Company of Medicine Table 3. Global Circular mRNA Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Circular mRNA Drugs Sales by Type (2021-2026) & (K Units) Table 5. Global Circular mRNA Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Circular mRNA Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Circular mRNA Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global Circular mRNA Drugs Price by Type (2021-2026) & (US$/Unit) Table 9. Global Circular mRNA Drugs Sales by Type (2027-2032) & (K Units) Table 10. Global Circular mRNA Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Circular mRNA Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Circular mRNA Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global Circular mRNA Drugs Price by Type (2027-2032) & (US$/Unit) Table 14. North America Circular mRNA Drugs Sales by Type (2021-2026) & (K Units) Table 15. North America Circular mRNA Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Circular mRNA Drugs Sales by Type (2021-2026) & (K Units) Table 17. Europe Circular mRNA Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Circular mRNA Drugs Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Circular mRNA Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Circular mRNA Drugs Sales by Type (2021-2026) & (K Units) Table 21. Latin America Circular mRNA Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Circular mRNA Drugs Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Circular mRNA Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Circular mRNA Drugs Industry Trends Table 25. Circular mRNA Drugs Industry Drivers Table 26. Circular mRNA Drugs Industry Opportunities and Challenges Table 27. Circular mRNA Drugs Industry Restraints Table 28. Global Circular mRNA Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Circular mRNA Drugs Revenue Market Share by Company (2021-2026) Table 30. Global Circular mRNA Drugs Sales by Company (2021-2026) & (K Units) Table 31. Global Circular mRNA Drugs Sales Share by Company (2021-2026) Table 32. Global Circular mRNA Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Circular mRNA Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Circular mRNA Drugs Major Company Production Sites and Headquarters Table 35. Global Circular mRNA Drugs Company, Product Type & Application Table 36. Global Circular mRNA Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Circular mRNA Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Circular mRNA Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Circular mRNA Drugs Sales by Region (2021-2026) & (K Units) Table 41. Global Circular mRNA Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Circular mRNA Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Circular mRNA Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global Circular mRNA Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Circular mRNA Drugs Sales by Region (2027-2032) & (K Units) Table 46. Global Circular mRNA Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Circular mRNA Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Circular mRNA Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global Circular mRNA Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Circular mRNA Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Circular mRNA Drugs Sales by Application (2021-2026) & (K Units) Table 52. Global Circular mRNA Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Circular mRNA Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Circular mRNA Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global Circular mRNA Drugs Price by Application (2021-2026) & (US$/Unit) Table 56. Global Circular mRNA Drugs Sales by Application (2027-2032) & (K Units) Table 57. Global Circular mRNA Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Circular mRNA Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Circular mRNA Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global Circular mRNA Drugs Price by Application (2027-2032) & (US$/Unit) Table 61. North America Circular mRNA Drugs Sales by Application (2021-2026) & (K Units) Table 62. North America Circular mRNA Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Circular mRNA Drugs Sales by Application (2021-2026) & (K Units) Table 64. Europe Circular mRNA Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Circular mRNA Drugs Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Circular mRNA Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Circular mRNA Drugs Sales by Application (2021-2026) & (K Units) Table 68. Latin America Circular mRNA Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Circular mRNA Drugs Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Circular mRNA Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Chimera Therapeutics Company Information Table 72. Chimera Therapeutics Business Overview Table 73. Chimera Therapeutics Circular mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Chimera Therapeutics Circular mRNA Drugs Product Portfolio Table 75. Chimera Therapeutics Recent Development Table 76. Orbital Therapeutics Company Information Table 77. Orbital Therapeutics Business Overview Table 78. Orbital Therapeutics Circular mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Orbital Therapeutics Circular mRNA Drugs Product Portfolio Table 80. Orbital Therapeutics Recent Development Table 81. Orna Therapeutics Company Information Table 82. Orna Therapeutics Business Overview Table 83. Orna Therapeutics Circular mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Orna Therapeutics Circular mRNA Drugs Product Portfolio Table 85. Orna Therapeutics Recent Development Table 86. Sail Biomedicines Company Information Table 87. Sail Biomedicines Business Overview Table 88. Sail Biomedicines Circular mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Sail Biomedicines Circular mRNA Drugs Product Portfolio Table 90. Sail Biomedicines Recent Development Table 91. Torque Bio Company Information Table 92. Torque Bio Business Overview Table 93. Torque Bio Circular mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Torque Bio Circular mRNA Drugs Product Portfolio Table 95. Torque Bio Recent Development Table 96. Aikang Pharmaceuticals Company Information Table 97. Aikang Pharmaceuticals Business Overview Table 98. Aikang Pharmaceuticals Circular mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Aikang Pharmaceuticals Circular mRNA Drugs Product Portfolio Table 100. Aikang Pharmaceuticals Recent Development Table 101. Edigene Company Information Table 102. Edigene Business Overview Table 103. Edigene Circular mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Edigene Circular mRNA Drugs Product Portfolio Table 105. Edigene Recent Development Table 106. CirCode Company Information Table 107. CirCode Business Overview Table 108. CirCode Circular mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. CirCode Circular mRNA Drugs Product Portfolio Table 110. CirCode Recent Development Table 111. Curemed Bio Company Information Table 112. Curemed Bio Business Overview Table 113. Curemed Bio Circular mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Curemed Bio Circular mRNA Drugs Product Portfolio Table 115. Curemed Bio Recent Development Table 116. Therorna Company Information Table 117. Therorna Business Overview Table 118. Therorna Circular mRNA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Therorna Circular mRNA Drugs Product Portfolio Table 120. Therorna Recent Development Table 121. North America Circular mRNA Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. North America Circular mRNA Drugs Sales by Country (2021-2026) & (K Units) Table 123. North America Circular mRNA Drugs Sales Market Share by Country (2021-2026) Table 124. North America Circular mRNA Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 125. North America Circular mRNA Drugs Sales Market Share Forecast by Country (2027-2032) Table 126. North America Circular mRNA Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Circular mRNA Drugs Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Circular mRNA Drugs Market Share by Country (2021-2026) Table 129. North America Circular mRNA Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Circular mRNA Drugs Market Share Forecast by Country (2027-2032) Table 131. Europe Circular mRNA Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Europe Circular mRNA Drugs Sales by Country (2021-2026) & (K Units) Table 133. Europe Circular mRNA Drugs Sales Market Share by Country (2021-2026) Table 134. Europe Circular mRNA Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 135. Europe Circular mRNA Drugs Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Circular mRNA Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Circular mRNA Drugs Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Circular mRNA Drugs Market Share by Country (2021-2026) Table 139. Europe Circular mRNA Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Circular mRNA Drugs Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Circular mRNA Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Circular mRNA Drugs Sales by Country (2021-2026) & (K Units) Table 143. Asia-Pacific Circular mRNA Drugs Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Circular mRNA Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 145. Asia-Pacific Circular mRNA Drugs Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Circular mRNA Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Circular mRNA Drugs Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Circular mRNA Drugs Market Share by Country (2021-2026) Table 149. Asia-Pacific Circular mRNA Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Circular mRNA Drugs Market Share Forecast by Country (2027-2032) Table 151. Latin America Circular mRNA Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Latin America Circular mRNA Drugs Sales by Country (2021-2026) & (K Units) Table 153. Latin America Circular mRNA Drugs Sales Market Share by Country (2021-2026) Table 154. Latin America Circular mRNA Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 155. Latin America Circular mRNA Drugs Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Circular mRNA Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Circular mRNA Drugs Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Circular mRNA Drugs Market Share by Country (2021-2026) Table 159. Latin America Circular mRNA Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Circular mRNA Drugs Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Circular mRNA Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Circular mRNA Drugs Sales by Country (2021-2026) & (K Units) Table 163. Middle East and Africa Circular mRNA Drugs Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Circular mRNA Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 165. Middle East and Africa Circular mRNA Drugs Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Circular mRNA Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Circular mRNA Drugs Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Circular mRNA Drugs Market Share by Country (2021-2026) Table 169. Middle East and Africa Circular mRNA Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Circular mRNA Drugs Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Circular mRNA Drugs Distributors List Table 174. Circular mRNA Drugs Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Circular mRNA Drugs Image Figure 2. Global Circular mRNA Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Circular mRNA Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Circular mRNA Drugs Sales (2021-2032) & (K Units) Figure 5. Preventive Medicine Image Figure 6. Global Preventive Medicine Sales YoY Growth (2021-2032) & (K Units) Figure 7. Medicine Image Figure 8. Global Medicine Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Circular mRNA Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Circular mRNA Drugs Market Share by Type 2025 VS 2032 Figure 11. North America Circular mRNA Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America Circular mRNA Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe Circular mRNA Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Circular mRNA Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Circular mRNA Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Circular mRNA Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Circular mRNA Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Circular mRNA Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Circular mRNA Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Circular mRNA Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Circular mRNA Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Infectious Disease Image Figure 24. Global Infectious Disease Sales YoY Growth (2021-2032) & (K Units) Figure 25. Cancer Image Figure 26. Global Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Circular mRNA Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Circular mRNA Drugs Market Share by Application 2025 VS 2032 Figure 31. North America Circular mRNA Drugs Sales Market Share in Volume by Application in 2025 Figure 32. North America Circular mRNA Drugs Sales Market Share in Value by Application in 2025 Figure 33. Europe Circular mRNA Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Europe Circular mRNA Drugs Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Circular mRNA Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Circular mRNA Drugs Sales Market Share in Value by Application in 2025 Figure 37. Latin America Circular mRNA Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Circular mRNA Drugs Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Circular mRNA Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Circular mRNA Drugs Sales Market Share in Value by Application in 2025 Figure 41. North America Circular mRNA Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Circular mRNA Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Circular mRNA Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Circular mRNA Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Circular mRNA Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Circular mRNA Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Circular mRNA Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Circular mRNA Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Circular mRNA Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Circular mRNA Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Circular mRNA Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Circular mRNA Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Circular mRNA Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Circular mRNA Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Circular mRNA Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Circular mRNA Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Circular mRNA Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Circular mRNA Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Circular mRNA Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Circular mRNA Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Circular mRNA Drugs Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Circular mRNA Drugs Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Preventive Medicine
  • Medicine
Applications
  • Infectious Disease
  • Cancer
  • Others
Companies covered
  • Chimera Therapeutics
  • Orbital Therapeutics
  • Orna Therapeutics
  • Sail Biomedicines
  • Torque Bio
  • Aikang Pharmaceuticals
  • Edigene
  • CirCode
  • Curemed Bio
  • Therorna

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Circular mRNA Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Circular mRNA Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Circular mRNA Drugs Market by Type
  6. 1.3.1 Preventive Medicine
  7. 1.3.2 Medicine
  8. 1.4 Global Circular mRNA Drugs Market Size by Type
  9. 1.4.1 Global Circular mRNA Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Circular mRNA Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Circular mRNA Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Circular mRNA Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Circular mRNA Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Circular mRNA Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Circular mRNA Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Circular mRNA Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Circular mRNA Drugs Industry Trends
  2. 2.2 Circular mRNA Drugs Industry Drivers
  3. 2.3 Circular mRNA Drugs Industry Opportunities and Challenges
  4. 2.4 Circular mRNA Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Circular mRNA Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Circular mRNA Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Circular mRNA Drugs Price (2021-2026)
  4. 3.4 Global Circular mRNA Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Circular mRNA Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Circular mRNA Drugs Company, Product Type & Application
  7. 3.7 Global Circular mRNA Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Circular mRNA Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Circular mRNA Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Circular mRNA Drugs Tier 1, Tier 2, and Tier 3
4 Circular mRNA Drugs Regional Status and Outlook
  1. 4.1 Global Circular mRNA Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Circular mRNA Drugs Historic Market Size by Region
  3. 4.2.1 Global Circular mRNA Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Circular mRNA Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Circular mRNA Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Circular mRNA Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Circular mRNA Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Circular mRNA Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Circular mRNA Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Circular mRNA Drugs by Application
  1. 5.1 Circular mRNA Drugs Market by Application
  2. 5.1.1 Infectious Disease
  3. 5.1.2 Cancer
  4. 5.1.3 Others
  5. 5.2 Global Circular mRNA Drugs Market Size by Application
  6. 5.2.1 Global Circular mRNA Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Circular mRNA Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Circular mRNA Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Circular mRNA Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Circular mRNA Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Circular mRNA Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Circular mRNA Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Circular mRNA Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Chimera Therapeutics
  2. 6.1.1 Chimera Therapeutics Company Information
  3. 6.1.2 Chimera Therapeutics Business Overview
  4. 6.1.3 Chimera Therapeutics Circular mRNA Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Chimera Therapeutics Circular mRNA Drugs Product Portfolio
  6. 6.1.5 Chimera Therapeutics Recent Developments
  7. 6.2 Orbital Therapeutics
  8. 6.2.1 Orbital Therapeutics Company Information
  9. 6.2.2 Orbital Therapeutics Business Overview
  10. 6.2.3 Orbital Therapeutics Circular mRNA Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Orbital Therapeutics Circular mRNA Drugs Product Portfolio
  12. 6.2.5 Orbital Therapeutics Recent Developments
  13. 6.3 Orna Therapeutics
  14. 6.3.1 Orna Therapeutics Company Information
  15. 6.3.2 Orna Therapeutics Business Overview
  16. 6.3.3 Orna Therapeutics Circular mRNA Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Orna Therapeutics Circular mRNA Drugs Product Portfolio
  18. 6.3.5 Orna Therapeutics Recent Developments
  19. 6.4 Sail Biomedicines
  20. 6.4.1 Sail Biomedicines Company Information
  21. 6.4.2 Sail Biomedicines Business Overview
  22. 6.4.3 Sail Biomedicines Circular mRNA Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sail Biomedicines Circular mRNA Drugs Product Portfolio
  24. 6.4.5 Sail Biomedicines Recent Developments
  25. 6.5 Torque Bio
  26. 6.5.1 Torque Bio Company Information
  27. 6.5.2 Torque Bio Business Overview
  28. 6.5.3 Torque Bio Circular mRNA Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Torque Bio Circular mRNA Drugs Product Portfolio
  30. 6.5.5 Torque Bio Recent Developments
  31. 6.6 Aikang Pharmaceuticals
  32. 6.6.1 Aikang Pharmaceuticals Company Information
  33. 6.6.2 Aikang Pharmaceuticals Business Overview
  34. 6.6.3 Aikang Pharmaceuticals Circular mRNA Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Aikang Pharmaceuticals Circular mRNA Drugs Product Portfolio
  36. 6.6.5 Aikang Pharmaceuticals Recent Developments
  37. 6.7 Edigene
  38. 6.7.1 Edigene Company Information
  39. 6.7.2 Edigene Business Overview
  40. 6.7.3 Edigene Circular mRNA Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Edigene Circular mRNA Drugs Product Portfolio
  42. 6.7.5 Edigene Recent Developments
  43. 6.8 CirCode
  44. 6.8.1 CirCode Company Information
  45. 6.8.2 CirCode Business Overview
  46. 6.8.3 CirCode Circular mRNA Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 CirCode Circular mRNA Drugs Product Portfolio
  48. 6.8.5 CirCode Recent Developments
  49. 6.9 Curemed Bio
  50. 6.9.1 Curemed Bio Company Information
  51. 6.9.2 Curemed Bio Business Overview
  52. 6.9.3 Curemed Bio Circular mRNA Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Curemed Bio Circular mRNA Drugs Product Portfolio
  54. 6.9.5 Curemed Bio Recent Developments
  55. 6.10 Therorna
  56. 6.10.1 Therorna Company Information
  57. 6.10.2 Therorna Business Overview
  58. 6.10.3 Therorna Circular mRNA Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Therorna Circular mRNA Drugs Product Portfolio
  60. 6.10.5 Therorna Recent Developments
7 North America by Country
  1. 7.1 North America Circular mRNA Drugs Sales by Country
  2. 7.1.1 North America Circular mRNA Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Circular mRNA Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Circular mRNA Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Circular mRNA Drugs Market Size by Country
  6. 7.2.1 North America Circular mRNA Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Circular mRNA Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Circular mRNA Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Circular mRNA Drugs Sales by Country
  2. 8.1.1 Europe Circular mRNA Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Circular mRNA Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Circular mRNA Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Circular mRNA Drugs Market Size by Country
  6. 8.2.1 Europe Circular mRNA Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Circular mRNA Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Circular mRNA Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Circular mRNA Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Circular mRNA Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Circular mRNA Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Circular mRNA Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Circular mRNA Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Circular mRNA Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Circular mRNA Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Circular mRNA Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Circular mRNA Drugs Sales by Country
  2. 10.1.1 South America Circular mRNA Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Circular mRNA Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Circular mRNA Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Circular mRNA Drugs Market Size by Country
  6. 10.2.1 South America Circular mRNA Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Circular mRNA Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Circular mRNA Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Circular mRNA Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Circular mRNA Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Circular mRNA Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Circular mRNA Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Circular mRNA Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Circular mRNA Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Circular mRNA Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Circular mRNA Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Circular mRNA Drugs Value Chain Analysis
  2. 12.1.1 Circular mRNA Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Circular mRNA Drugs Production Mode & Process
  7. 12.2 Circular mRNA Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Circular mRNA Drugs Distributors
  10. 12.2.3 Circular mRNA Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst